The Impact of Music Intervention on Sleep - Trial NCT06088810
Access comprehensive clinical trial information for NCT06088810 through Pure Global AI's free database. This phase not specified trial is sponsored by Rutgers, The State University of New Jersey and is currently Not yet recruiting. The study focuses on Dementia. Target enrollment is 144 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Rutgers, The State University of New Jersey
Timeline & Enrollment
N/A
Jun 01, 2024
Aug 01, 2026
Primary Outcome
Acceptability
Summary
The primary purpose of this Stage 1b NIH-funded clinical trial (K23AG073618, PI Petrovsky) is
 to determine the efficacy of a 1-month music intervention (Calming Music Personalized for
 Sleep Enhancement in PeRsons living with Dementia, CoMPoSER) on health outcomes in 72 dyads
 (144 participants) of persons living with dementia (PLWD) and their caregivers (Stage 1b).
 The secondary purpose of this research project is to examine the mechanism of stress
 reduction and sustained effects of the music intervention on PLWD and caregiver well-being.
 We will evaluate the acceptability of the mobile application CoMPoSER in a pilot RCT and
 determine the impact of the mobile application CoMPoSER on PLWD (sleep latency, sleep
 efficiency, wake after sleep onset, total sleep time, sleep quality) and caregiver (perceived
 stress and well-being) outcomes.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06088810
Non-Device Trial